AFFiRiS's Unattributed VC - II Round

AFFiRiS raised a round of funding on June 23, 2016.

AFFiRiS develops tailor-made therapeutic peptide vaccines against chronic diseases. Currently, its clinical pipeline consists of 3 drug candidates against Parkinson's, MSA and Hypercholesterolemia. Fu…

Articles about AFFiRiS's Unattributed VC - II Round: